Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 15, 2023

BUY
$0.22 - $0.5 $3,256 - $7,400
14,800 New
14,800 $4,000
Q1 2023

May 15, 2023

BUY
$0.36 - $0.63 $2,340 - $4,095
6,500 Added 40.12%
22,700 $9,000
Q4 2022

Feb 14, 2023

BUY
$0.41 - $18.6 $6,642 - $301,320
16,200 New
16,200 $8,000
Q1 2022

May 16, 2022

SELL
$1.16 - $2.5 $28,535 - $61,500
-24,600 Reduced 42.78%
32,900 $47,000
Q4 2021

Feb 14, 2022

BUY
$2.46 - $8.74 $82,410 - $292,790
33,500 Added 139.58%
57,500 $147,000
Q3 2021

Nov 12, 2021

SELL
$5.1 - $9.39 $151,470 - $278,883
-29,700 Reduced 55.31%
24,000 $200,000
Q2 2021

Aug 06, 2021

BUY
$3.95 - $6.88 $128,375 - $223,600
32,500 Added 153.3%
53,700 $340,000
Q1 2021

May 14, 2021

BUY
$2.01 - $5.55 $42,611 - $117,660
21,200 New
21,200 $98,000

Others Institutions Holding PAVM

# of Institutions
1
Shares Held
2.24M
Call Options Held
0
Put Options Held
0

About PAVmed Inc.


  • Ticker PAVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 90,999,104
  • Market Cap $60.1M
  • Description
  • PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...
More about PAVM
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.